Evidence map›Paper›PMID 41329744›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

Structure of human green cone opsin yields insights into mechanisms underlying the rapid decay of its active, signaling state.

Weekie Yao, Jonathan F Fay, David L Farrens

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. E122Q rhodopsin: pigment microspectrophotometry, photoreceptor light responses, and bleaching adaptation.Journal of comparative physiology. A, Neuroethology, sensory, neural, and behavioral physiology · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Weekie YaoDepartment of Chemical Physiology and Biochemistry, Oregon Health and Science University, Portland, OR 97239.ORCID 0000-0002-0684-8438
Jonathan F FayDepartment of Biochemistry and Molecular Biology, University of Maryland Baltimore, Baltimore, MD 21201.ORCID 0000-0003-1822-2384
David L FarrensDepartment of Chemical Physiology and Biochemistry, Oregon Health and Science University, Portland, OR 97239.ORCID 0000-0003-2761-4769

Funding

Pacific Northwest Center for Cryo-EM - Screening supplementU24GM129547 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI EVANS, JAMES E, GOUAUX, JAMES E · 2018 to 2023
$54.8M
Structural Dynamics in Rhodopsin Activation and AttenuationR01EY029343 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI David L Farrens · 2019 to 2026
$2.9M
HHS | NIH | National Eye Institute (NEI) EY029343HHS | NIH | National Institute of General Medical Sciences (NIGMS) U24GM129547NEI NIH HHS R01 EY029343NIGMS NIH HHS U24 GM129547
6 · The paper itself

Abstract

Cone opsins enable daylight vision and color discrimination. Like their dim-light cousin rhodopsin (Rho) found in rod cells, they use a covalently attached retinal ligand to sense light and initiate visual phototransduction by activating G proteins. Unfortunately, we know less about their structural properties, in part because their activated state is unstable-cone opsins release their retinal agonist within seconds after light activation, ~100× faster than Rho. To determine what causes this rapid release and how it affects G protein activation, we solved the structure of active-state, wild-type human green cone opsin (GCO

Indexed as

Cone OpsinsHumansModels, MolecularProtein ConformationRetinal Cone Photoreceptor CellsRhodopsinSignal TransductionCone OpsinsRhodopsincone opsin functioncone opsin structureGPCRsvisual signal transduction

Identifiers

PMID41329744
PMCPMC12704717

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.